This is a StreetInsider.com Premium Only Page

Heron Therapeutics (HRTX) –

Apr 19, 2024 05:48 PM Form 4 HERON THERAPEUTICS, INC. For: Apr 19 Filed by: Duarte Ira

Apr 19, 2024 05:22 PM Form PRE 14A HERON THERAPEUTICS, INC. For: Jun 13

Apr 19, 2024 05:03 PM Form 4 HERON THERAPEUTICS, INC. For: Apr 19 Filed by: Forbes William P

Apr 19, 2024 04:35 PM Form 4 HERON THERAPEUTICS, INC. For: Apr 19 Filed by: Collard Craig A

Apr 11, 2024 04:05 PM Heron Therapeutics to Host Investor Day on May 15, 2024 in New York City

Apr 5, 2024 03:57 PM Form 4 HERON THERAPEUTICS, INC. For: Apr 03 Filed by: Collard Craig A

Mar 28, 2024 04:05 PM Heron Therapeutics Announces Presentation at the 23rd Annual Needham Virtual Healthcare Conference

Mar 21, 2024 04:34 PM Form 8-K HERON THERAPEUTICS, INC. For: Mar 18

Mar 13, 2024 07:09 AM Heron Therapeutics (HRTX) PT Raised to $5 at Needham to reflect strong sales trends

Mar 12, 2024 04:16 PM Form 10-K HERON THERAPEUTICS, INC. For: Dec 31

Mar 12, 2024 04:10 PM Form 8-K HERON THERAPEUTICS, INC. For: Mar 12

Mar 12, 2024 04:08 PM Heron Therapeutics (HRTX) Tops Q4 EPS by 9c, provides guidance

Mar 12, 2024 04:05 PM Heron Therapeutics Announces Fourth Quarter and Full-Year 2023 Financial Results and Highlights Recent Corporate Updates

Feb 28, 2024 08:00 AM Heron Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results On Tuesday, March 12, 2024

Feb 14, 2024 04:38 PM Form SC 13G/A HERON THERAPEUTICS, INC. Filed by: GREAT POINT PARTNERS LLC

Feb 14, 2024 04:22 PM Form SC 13G/A HERON THERAPEUTICS, INC. Filed by: BAKER BROS. ADVISORS LP

Feb 14, 2024 08:46 AM Form SC 13G/A HERON THERAPEUTICS, INC. Filed by: Deep Track Capital, LP

Feb 13, 2024 05:10 PM Form SC 13G/A HERON THERAPEUTICS, INC. Filed by: VANGUARD GROUP INC

Feb 6, 2024 11:43 AM Form SC 13G/A HERON THERAPEUTICS, INC. Filed by: FRANKLIN RESOURCES INC

Jan 24, 2024 08:01 AM Form 8-K HERON THERAPEUTICS, INC. For: Jan 23

Jan 24, 2024 04:23 AM Heron Therapeutics (HRTX) Announces FDA Approval of ZYNRELEF Indication Expansion to Include Additional Orthopedic and Soft Tissue Procedures

Jan 23, 2024 08:00 PM Heron Therapeutics Announces FDA Approval of ZYNRELEF® Indication Expansion to Include Additional Orthopedic and Soft Tissue Procedures

Jan 19, 2024 09:06 PM Form 4 HERON THERAPEUTICS, INC. For: Jan 19 Filed by: Christian Waage

Jan 19, 2024 09:05 PM Form 4 HERON THERAPEUTICS, INC. For: Jan 19 Filed by: Rodriguez Susan

Jan 19, 2024 09:05 PM Form 4 HERON THERAPEUTICS, INC. For: Jan 19 Filed by: Morgan Adam

Jan 19, 2024 09:04 PM Form 4 HERON THERAPEUTICS, INC. For: Jan 19 Filed by: Johnson Craig A

Jan 19, 2024 09:03 PM Form 4 HERON THERAPEUTICS, INC. For: Jan 19 Filed by: Dissanaike Sharmila

Jan 19, 2024 09:02 PM Form 4 HERON THERAPEUTICS, INC. For: Jan 19 Filed by: Peraza Lisa

Jan 19, 2024 09:02 PM Form 4 HERON THERAPEUTICS, INC. For: Jan 19 Filed by: Forbes William P

Jan 19, 2024 09:01 PM Form 4 HERON THERAPEUTICS, INC. For: Jan 19 Filed by: Duarte Ira

Jan 19, 2024 08:59 PM Form 4 HERON THERAPEUTICS, INC. For: Jan 19 Filed by: Collard Craig A

Jan 16, 2024 05:19 PM Form 4 HERON THERAPEUTICS, INC. For: Jan 13 Filed by: Peraza Lisa

Jan 11, 2024 04:07 PM Form 8-K HERON THERAPEUTICS, INC. For: Jan 05

Jan 8, 2024 05:23 AM Heron Therapeutics (HRTX) Announces Partnership with CrossLink Life Sciences to Expand Promotion for ZYNRELEF

Jan 7, 2024 05:00 PM Heron Therapeutics Announces Partnership with CrossLink Life Sciences to Expand Promotional Effort for ZYNRELEF®, the First and Only Non-Opioid Dual Acting Local Anesthetic for Post-Operative Pain

Dec 22, 2023 04:48 PM Heron Therapeutics (HRTX) Receives Notice from Mylan Pharmaceuticals Advising Mylan Seeks Approval for Generic Version of APONVIE

Dec 22, 2023 04:30 PM Form 8-K HERON THERAPEUTICS, INC. For: Dec 18

Dec 21, 2023 05:30 PM Heron Therapeutics (HRTX) Announces Resignation of Kevin Kotler from Board

Dec 21, 2023 05:26 PM Form 8-K HERON THERAPEUTICS, INC. For: Dec 20

Dec 7, 2023 02:46 PM Form SC 13G/A HERON THERAPEUTICS, INC. Filed by: JPMORGAN CHASE & CO

Dec 6, 2023 04:48 PM Form SC 13G/A HERON THERAPEUTICS, INC. Filed by: BlackRock Inc.

Nov 21, 2023 12:19 PM Form 4 HERON THERAPEUTICS, INC. For: Nov 17 Filed by: Forbes William P

Nov 20, 2023 10:08 AM Form 4 HERON THERAPEUTICS, INC. For: Nov 16 Filed by: Forbes William P

Nov 17, 2023 12:38 PM Form 4 HERON THERAPEUTICS, INC. For: Nov 16 Filed by: Collard Craig A

Nov 17, 2023 12:37 PM Form 4 HERON THERAPEUTICS, INC. For: Nov 16 Filed by: Duarte Ira

Nov 15, 2023 04:56 PM U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.47%

Nov 15, 2023 07:56 AM Heron Therapeutics (HRTX) PT Lowered to $2.50 at TD Cowen

Nov 15, 2023 07:13 AM Heron Therapeutics (HRTX) PT Lowered to $4 at Needham & Company

Nov 14, 2023 06:44 PM Form 10-Q HERON THERAPEUTICS, INC. For: Sep 30

Nov 14, 2023 04:47 PM Form 8-K HERON THERAPEUTICS, INC. For: Nov 14